Company intelligence / Profile preview

Inanovate

Jacksonville Township, North Carolina, USA

Ownership: Private
Employees: ~11
Development stage: Other

Overview

Inanovate has developed and benchmarked the Bio-ID platform integrating Longitudinal Assay Screening (LAS), enabling accurate and rapid detection of multiple proteins/biomarkers from blood samples. It has been validated for applications such as breast cancer biomarker detection and therapy monitoring, allowing high-sensitivity, low-cost, multiplexed diagnostics with minimal sample requirements.

Therapeutic areas: OncologyOther
Modalities: DeviceDiagnostic technology
Industry: Protein Biomarker Diagnostics

Partnerships

Sanford Research (clinical/academic collaboration for breast cancer diagnostics)Unspecified commercial/academic partners in Massachusetts, North Carolina, and the UK

Beyond the preview

Go deeper on Inanovate.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inanovate.

Explore the full profile